Innoup Pharma- Biotechnology
Sodena and the venture capital company Inveready invested in October 2015 €2M in Innoup Pharmaa company dedicated to the application of nanoparticle technology in oral cancer drugs to decrease toxicity.
With this round, the company was able to complete the regulatory preclinical development of one of the leading intravenous anticancer drugs targeted at metastatic breast cancer.
InnoUp expects in less than two years to attract interest from other investors for further development and the securing of a relevant licensing agreement.
Davalor Health- Tics e-health
Davalor is a vision assessment system, called EVA, which operates autonomously and is connected to the company's databases. Using dynamic images and video games in "true 3D", it stimulates the eyes and brain and measures responses according to 75 clinical parameters.
The company had previously raised €12M through crowdfunding on the Bestaker platform.
The investment of Sodena arrived at a time when the company had not yet started selling its product. With no income and with payment obligations to employees and suppliers.
Currently, it appears that a Chinese industrial group wants to invest €17M in the company, to acquire the 25% and provide immediate liquidity.
Iden Biotech- Agroalimentario
Sodena contributed €1M, in a €4M round in the company Iden Biotech, led by CRB Inverbio.
Iden Biotechnologyfounded in 2005, has two main lines of work: the identification and development of plant genes of agronomic value to improve the production of crops of agronomic interest and the development of products of biological origin which, when applied to crops, give them greater resistance and productivity, allowing a significant reduction in the use of agrochemicals.
Apex is a company based in Ribaforada, which produces snacks, including the famous Aspitos.
The current Apex has little or nothing to do with the one in which Sodena invested €1.6m in 2008. At that time, the company was owned by the Borges group. While Apex's management was committed to growth through the acquisition of companies, the Borges group was not willing to invest.
Thus, in 2008, Sodena became a shareholder. It invested €1.6M and took 28.56%. Together with Sodena, it also became a shareholder. Major Key through the funds Punto Futuro (28.56%) and Real de Vellón (7%). Between Sodena and Clave Mayor they had control of the shareholding.
Apex's turnover grew from €10.7m in 2008 to €50m in 2015 and its workforce grew from 95 people to 230. In February 2011, they acquired the Valencian firm Papas Vidal and five months later, in July, they acquired another in León.
If you are looking for financing, contact us. Abra-Invest has a team of experts in alternative financing at your disposal. Call + 34 946424142 or fill in the contact form.
Other posts that may interest you
Wallapop, Letgo and HallStreet: M&A Spanish companies to gain strength in international market
Diversion of venture capital in Spanish companies: Tyba and Otogami